Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

727
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
727
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

1.3K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.3K
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

1.3K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
1.3K
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

716
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
716

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fighter Pilot Syndrome: A Bow Hunter Syndrome Variant Identified With Dynamic Cerebral Angiography.

Stroke (Hoboken, N.J.)·2026
Same author

Unravelling the molecular network of desiccation tolerance in resurrection plants started with the model plant Craterostigma plantagineum.

Planta·2025
Same author

Long Term Results of a Comparative Study of Percutaneous and Surgically Created Proximal Forearm Arteriovenous Fistulae.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2025
Same author

The Complete Inpatient Record Using Comprehensive Electronic Data (CIRCE) project: A team-based approach to clinically validated, research-ready electronic health record data.

Learning health systems·2025
Same author

The Vecta 46 intermediate catheter for mechanical thrombectomy of distal medium vessel occlusions: A single-center experience.

Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences·2024
Same author

Global geoepidemiology of gastrointestinal surgery rates in Crohn's disease.

World journal of gastrointestinal surgery·2024

Related Experiment Video

Updated: Jan 3, 2026

Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke
08:53

Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke

Published on: June 6, 2025

1.4K

Antidepressant Use for Improving Functional Ischemic Stroke Outcomes.

Caleb J Heiberger1, Clayton Busch2, Kevin Rance3

  • 1Radiology, University of South Dakota Sanford School of Medicine, Sioux Falls, USA.

Cureus
|November 29, 2019
PubMed
Summary
This summary is machine-generated.

Antidepressant use after stroke improved survival rates for all patients and enhanced functional recovery in severe stroke cases. This suggests a potential benefit of antidepressants in post-stroke care, particularly for those with significant neurological deficits.

Keywords:
antidepressantfunctionalischemic strokestroke

More Related Videos

A Middle Cerebral Artery Occlusion Technique for Inducing Post-stroke Depression in Rats
04:38

A Middle Cerebral Artery Occlusion Technique for Inducing Post-stroke Depression in Rats

Published on: May 22, 2019

10.8K
Methods to Quantify Pharmacologically Induced Alterations in Motor Function in Human Incomplete SCI
14:55

Methods to Quantify Pharmacologically Induced Alterations in Motor Function in Human Incomplete SCI

Published on: April 18, 2011

14.1K

Related Experiment Videos

Last Updated: Jan 3, 2026

Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke
08:53

Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke

Published on: June 6, 2025

1.4K
A Middle Cerebral Artery Occlusion Technique for Inducing Post-stroke Depression in Rats
04:38

A Middle Cerebral Artery Occlusion Technique for Inducing Post-stroke Depression in Rats

Published on: May 22, 2019

10.8K
Methods to Quantify Pharmacologically Induced Alterations in Motor Function in Human Incomplete SCI
14:55

Methods to Quantify Pharmacologically Induced Alterations in Motor Function in Human Incomplete SCI

Published on: April 18, 2011

14.1K

Area of Science:

  • Neuroscience
  • Pharmacology
  • Clinical Neurology

Background:

  • Stroke is a leading cause of long-term disability.
  • Functional recovery post-stroke is a critical clinical challenge.
  • The role of pharmacotherapy, including antidepressants, in stroke recovery requires further elucidation.

Purpose of the Study:

  • To evaluate the impact of antidepressant use on functional recovery and survival in acute ischemic stroke patients.
  • To specifically analyze outcomes in a subgroup of patients with severe stroke (NIHSS ≥ 21).

Main Methods:

  • Retrospective analysis of an institutional database of ischemic stroke patients.
  • Intention-to-treat grouping based on antidepressant use post-stroke.
  • Assessment of modified Rankin Scale (mRS) and survival at 18 months.
  • Statistical analysis using adjusted logarithmic-multivariate and Cox proportional hazards models.

Main Results:

  • Patients receiving antidepressants demonstrated significantly higher survival rates (88% vs. 79%, HR 0.62, p < 0.01) compared to the non-antidepressant group.
  • In severe stroke cases, antidepressant use was associated with improved survival (79% vs. 60%, HR 0.36, p=0.026) and better mRS scores (3.9 vs 5, p < 0.01).
  • Demographic variables were controlled for, and significance was retained.

Conclusions:

  • Antidepressant administration post-stroke may enhance functional outcomes, especially in patients with severe stroke.
  • Antidepressants may reduce all-cause mortality in stroke patients across all severity levels.
  • Further prospective studies are warranted to confirm these findings and establish causality.